ArticleViruses2022
Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab.
Shigeru Fujita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleViruses2022
Shigeru Fujita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.